Top 10 Pre-Market Analyst Upgrades & Downgrades (ACTI, BCE, KSU, MYL, TEVA, AXP, AAPL, ROCK, SNV, TKC)

It is getting rather thin in analyst coverage, but these are the top ten analyst upgrades and downgrades we have seen this Wednesday morning:

• ActivIdentity (NASDAQ: ACTI) Started as Buy at Stanford Group.
• BCE (NYSE:BCE) Raised to Buy at UBS.
• Kansas City Southern (NYSE:KSU) Raised to Buy at UBS.
• Mylan (NYSE:MYL) Started as Overweight at JPMorgan.
• Teva (NASDAQ: TEVA) Started as Overweight at JPMorgan.
• American Express (NYSE:AXP) Started as Reduce at SunTrust Robinson Humphrey.
• Apple (NASDAQ: AAPL) Cut to Perform at Oppenheimer.
• Gibralter (NASDAQ: ROCK) Cut to Sell at Piper Jaffray.
• Synovus Financial (NYSE:SNV) Cut to Neutral at JPMorgan.
• Turkcell (NYSE:TKC) Cut to Neutral at JPMorgan.

Jon C. Ogg
December 17, 2008

Travel Cards Are Getting Too Good To Ignore (sponsored)

Credit card companies are pulling out all the stops, with the issuers are offering insane travel rewards and perks.

We’re talking huge sign-up bonuses, points on every purchase, and benefits like lounge access, travel credits, and free hotel nights. For travelers, these rewards can add up to thousands of dollars in flights, upgrades, and luxury experiences every year.

It’s like getting paid to travel — and it’s available to qualified borrowers who know where to look.

We’ve rounded up some of the best travel credit cards on the market. Click here to see the list. Don’t miss these offers — they won’t be this good forever.